Read how NNE's conceptual design accommodates Emergent Biosolution's need for flexibility and rapid changeover in its filling facility.
Setting new records With an investment of USD 200 million and nine buildings with a floor space of 12,700 m 2 , the facility is the largest enzyme plant dedicated to biofuel in North America .
NNE helped streamline Pfizer's verification systems. Read how the large ASTM implementation made commissioning and qualification more cost-effective.
Read how NNE supported Libbs Farmacêutica with a single-use monoclonal antibody (mAb) capacity expansion.
Read how NNE helped a US customer expand its filling capacity with a minimum of shutdown time.
Read how we are helping our customer refurbish a facility to transition from research to early clinical manufacturing of allogenic gene-edited cell therapies.
Read more about NNE's pharma engineering consultancy and owners representative services for Novo Nordisk's large scale greenfield API facility.